Cannabis News
Cannabis May Be Moved to a Schedule 3 Drug
Published
1 year agoon
By
admin
Cannabis to Schedule 3? Who are the Winners, the Whiners, and the Losers?
It has been over a week so how do you feel about the possible move coming for marijuana to go from a Schedule 1 drug to a Schedule 3 drug on the CSA?
The industry has been volleying opinions back and forth so I won’t bore you with the “it’s great, it’s not great” debate, you can read that stuf pretty much all over, including a nice piece by Cannabis Tech as they talked to 19 cannabis leaders about the HHS recommendation here. Cannabis.net also had a legacy stoner write up his opinion on the change and what it means in a piece called, “Lipstick on a Pig”.
In case you aren’t an avid follower of the weed industry or have been off the grid for a few weeks, let me update you on the big cannabis news. The Department of Health and Human Services has formally recommended that the Drug Enforcement Administration (DEA) reduce federal restrictions on marijuana despite its continued federal illegality. However, 40 states permit its use to varying degrees.
This action comes after President Joe Biden’s order to the leading health organization to carry out a thorough assessment of marijuana, which was given 11 months ago. The HHS recommends moving cannabis from being classified as a Schedule I drug to a Schedule III drug under the Controlled Substances Act.
According to the DEA, cannabis is classified alongside other Schedule I substances, such as heroin and LSD. This classification implies a perceived high potential for abuse and a lack of recognized medical utility.
If this recommendation became law, it would mark a huge and fundamental divergence from cannabis’s existing classification as a Schedule I drug. This categorization would change how people view marijuana by separating it from high-risk substances like heroin and recognizing its possible medical uses.
The HHS Recommendation to Reschedule
An HHS spokesperson conveyed that they promptly responded to the directive by submitting their recommendation to the DEA on August 29th.
Assistant Secretary for Health Rachel Levine stated that her recommendation was grounded in a thorough review by the Food and Drug Administration regarding the classification of marijuana. This review had been pledged following President Biden’s October pardon of federal offenses related to simple possession. At that time, President Biden tasked the HHS secretary and the U.S. Attorney General with assessing the federal scheduling of marijuana.
Cannabis would significantly change if the DEA reclassified it as a Schedule III substance, including the elimination of an IRS provision that forbade drug traffickers from deducting their business expenditures from their taxes (280E as it is so affectionately known as in the cannabis industry). The marijuana sector might be able to save hundreds of millions of dollars annually because of this change. According to NBC News, small business owners have stated that their inability to deduct what are normally thought of as regular business expenses is their biggest financial difficulty.
Now that HHS has made its recommendation, all attention is on the DEA, which holds the ultimate authority over substance scheduling. The DEA, not a historical fan of cannabis, could take years to review and make a decision.
According to five sources familiar with the planning, the Biden administration had aimed to announce the drug’s rescheduling in the Fall to coincide with the election cycle in 2024, approximately a year after the president’s request for the review. The duration of the DEA’s public review process remains uncertain at this point.
In response to inquiries, a DEA spokesperson confirmed, “We can confirm DEA received a letter from the Department of Health and Human Services providing its findings and recommendation on marijuana scheduling, pursuant to President Biden’s request for a review.” The spokesperson also stated, “DEA will now initiate its review.”
When questioned about the recommendation during a news briefing on Wednesday, White House press secretary Karine Jean-Pierre emphasized that the review is an independent process led by HHS and the Department of Justice. She declined to comment on President Biden’s current stance on the federal decriminalization of marijuana.
Response/Reactions to The Recommendation
The response to the HHS recommendation has garnered strong support within the corridors of Capitol Hill. In a statement, Senate Majority Leader Chuck Schumer commended HHS for taking a decisive step in the right direction. He urged the DEA to swiftly follow suit, emphasizing the importance of this move in significantly reducing the harm caused by stringent marijuana laws. Senator Schumer, a Democrat from New York, stressed that there remains a considerable legislative agenda to dismantle the federal cannabis prohibition and roll back the War on Drugs.
Advocates of marijuana legalization perceive this initial action as a momentous milestone. It signifies the federal government’s formal recognition of cannabis’s medical contributions for the very first time.
The Cannabis Industry Association emphasized the necessity of further harmonizing federal law with states where marijuana is legal while acknowledging the historical significance of the suggested reclassification. According to CEO Aaron Smith, delisting cannabis from the Controlled Substances Act and regulating it similarly to alcohol will ultimately address the complex issues arising from the federal-state conflict.
As both political parties look to use this issue as a political wedge in the run-up to the 2024 presidential election, relaxing federal marijuana laws also has political relevance. The majority of Americans support legalization, according to polls taken year over year since 2016.
Reps. Matt Gaetz, Greg Steube, and Brian Mast, all Republicans from Florida, have openly advocated for the drug to be rescheduled and urged the Biden administration to prioritize the endeavor. Although Florida voters legalized medicinal marijuana usage last year, Florida Governor Ron DeSantis has stepped up his opposition to decriminalizing and legalizing marijuana on the presidential campaign trail this week. The Florida Supreme Court is debating whether a ballot measure legalizing marijuana will appear in 2024.
Additionally, there is a bipartisan initiative underway in Congress aimed at simplifying the provision of banking services to legitimate cannabis businesses.
Senator Schumer has emphasized that passing the SAFE Banking Act, as it’s known, will be of utmost importance when the Senate reconvenes in September. However, the potential for a government shutdown could pose challenges to this object bill’s proponents of the bill to resolve a deadlock that emerged concerning the August recess.
One of the primary reasons why cannabis enterprises continue to struggle with limited access to financial services, obstacles in conducting medical research, and restrictions on the interstate transportation of products approved for medical use in numerous U.S. states is the current Schedule I classification of marijuana. Despite the widespread acceptance of medical marijuana, only the FDA possesses the legal authority to approve medications for medical use throughout the United States.
Bottom Line – Who are the Winners, the Whiners, and the Losers?
Winners – The cannabis industry in general, the black market, and MSOs. One, regardless of what you think schedule 3 will ultimately mean, pharma taking over the whole industry or not, it is better than a schedule 1 drug, period. If you are a conspiracy theorist and believe this is Big Pharma’s move to control prescriptions and the industry, so be it, time will tell, but getting cannabis off the “spend the rest of your life in prison” drug list, is the #1 win of the whole thing, let the chips fall where they may in the future. This writer does not feel this is the trojan horse some have made it out to be and Big Pharma will rule cannabis forever going forward. 3 < 1, win!
The second biggest winners, and a groan will go out from all the legacy cannabis people, the MSOs, or multistate operators will be BIG financial winners in this one. Basically, the bigger your expenses and operation, the more damage 280E and the inability to write off any of those expenses, did to your bottom line. If you reverse that same equation and take 280E off those financial statements, all those expenses now become tax write-offs, saving the MSO hundreds of millions of dollars in tax credit or refunds. We caught wind of this strategy at the Benzinga Cannabis Conference where it was mentioned that none of the MSOs were actually paying the taxes, they were kicking the can down the road hoping for a descheduling or rescheduling of the drug. Once that happened, they could go to court and say they should have never paid those taxes in the first place as cannabis is no longer a schedule 1 drug, and at this point, that bat bleep crazy strategy actually worked! MJ BIZ picked up on this same theme recently in their article on the cash windfall coming to companies for the 280E tax classification change.
Third place winner, the black or illicit cannabis market. While already booming in the US and around the world, any instance of lessening of the punishment for getting caught selling or shipping cannabis will only encourage more aggressive business behavior. For example, if you get caught shipping 20lbs of a schedule 1 drug from California to New York, you were looking at life in jail. If that changes to a fine or something much less severe, you remove a disincentive, in economic terms, to not take an action. Hence, the opposite is true, you created more of an incentive to take chances, push the limits to get more profit because the punishment for getting caught will be much less severe. (Schedule 3 illegal drug shipment compared to a Schedule 1). The illicit market should sleep well at night if this change is made because the possible punishment for growing weed without a license and selling it out of your van or shipping it over the internet will not be much less than any time since 1952. There is now economic inventive for the illicit market to push the limits on growing, sending, and pricing, as getting caught “won’t be so bad” in historical perspective.
Fourth Place Winner – International Markets – UN drug treaties be damned as Canada and Colombia have already shown the world, as they have been shipping cannabis internationally for months if not years now, but any change to the “severity of US listings of the drug”, will only increase risk from companies in other countries to push the boundaries of international and US law. Anything that dissipates the sting of that law will only encourage more business aggression in shipping and growing cannabis. Similar to the black-market argument above, if the fines and repercussions are lessened by the US and the UN, you are inviting more risk and aggressive behavior to try and make a profit.
Honorable Mention Winner – The rumor and speculation mill. Ever since the announcement by the HHS, the rumor mill about what could happen, secret plans, what it really means, wake up people, don’t get fooled, happiest day of my life, stuff is going off the rails. One rumor is that it will only apply to medical marijuana and recreational will still be a schedule 1 drug. Hard to do since THC is the actual cannabinoid on the Schedule 1 list, so lowering it to schedule 3 would affect both recreational and medical. The biggest rumor is the cannabis industry will be place in the hands of the FDA and Big Pharma like we all feared from day #1 and all the local growers and providers will be shut out of the industry. Fat chance. They have been trying to shut down illegal cannabis since 1952, no luck, now legal in over 40 states in some form or another. Don’t count of the FDA and DEA hiring thousands of agents to try and snuff out state-legal cannabis operations and public companies.
Losers – It is hard to find a loser when you go from a schedule 1 to a schedule 3 drug without going into fear mongering about the FDA and Big Pharma. In general, MSOs are going to have way more cash and profits, so that won’t bode well for smaller companies trying to compete with the big boys. Those that want cannabis descheduled will hoot and holler, but that was never really a viable option. You aren’t going from “schedule 1 like cocaine and heroin” to “unscheduled like peanut butter” overnight. Cannabis does pass through the blood-brain barrier and get you high, it does impair your senses and alter your thoughts and concept of reality for a bit while using it, so descheduling, while sounding nice, was never really on the table unfortunately.
Interstate commerce is the next massive shoe to drop, so not sure how Schedule 3 will affect those companies that had to “silo” their whole operation in each state, having to go from seed to sale and production in each state they enter. If interstate commerce is opened up, then the industry will finally start to reach a state of economic equilibrium as you will know the price of a Snoop Leaf or Chong’s Choice blunt in California and Massachusetts. You will also know the fair price of a pound of Emerald Triangle legal weed vs a pound of Emerald Triangle illegal weed.
Whiners – The cannabis industry proletariat that are screaming “rescheduling is not enough, we need descheduling!”. These are the same people that say, “cannabis isn’t a drug, it’s a plant”. First off, almost all drugs come from plants or did in their infancy. Nicotine, caffeine, heroin, cocaine, and opium all “come from plants” and they are clearly drugs, so yes, cannabis is a plant and a drug. Its cannabinoids pass through the blood-brain barrier and get you high, it is a drug and plant, move on.
The words “don’t settle for rescheduling” have been part of many op-ed pieces about the HHS news, and for some reason, these people think the US government and the cannabis industry are some sort of equal parties or in negotiations about this subject. As Binder says in the Breakfast Club movie, “Not even close, bud!”. The word “settle” implies some sort of negotiations or bartering of the details, which is just not the case in the US government vs the marijuana industry. There are no negotiations or evidence the US government gives one iota what the marijuana industry wants, so to say “don’t settle” is a bit rich. It is like being at your sentencing in front of judge where you get 2 years in jail and saying, “I won’t settle for that, I want less!”. Umm, yeah, it doesn’t work that way, the US government is the judge, and they decide the status of cannabis based on voters and future election results that the present party in office is worried about, not what the marijuana industry wants to see.
What if we all decide “not to settle for Schedule 3”? Now what? Oh yeah, nothing we can do since as a group we have very limited power and influence in politics. The industry is an outlier, we have cut lobbying money down to the bare bones in DC, no one of influence cares what we want or think, they are looking out for votes and power-broker money, think about what Big Tobacco and Big Pharma want, that is what is on their minds as they write the big checks in DC.
It isn’t up to us to settle; we sound like bratty little kids who just got their first dinner in months and are complaining it didn’t come with a dinner roll and desert. Take the Schedule 3 W when and if it comes and live to fight another day. Win the battle and keep fighting the war.
MORE ON A POSSIBLE SCHEDULE 3 MOVE, READ ON…
Cannabis News
America’s Constitutional Conundrum: Guns and Ganja
Published
1 day agoon
January 21, 2025By
admin
Of Guns and Ganja: America’s Constitutional Conundrum
If there’s one thing America is famous for, it’s guns – and lots of ’em! In the land of the free and home of the brave, firearms aren’t just a right, they’re practically a national pastime. With over 400 million firearms floating around a nation of 330 million people, it’s safe to say that guns are as American as apple pie and baseball.
But you know what else Americans love? Drugs. The US remains the world’s largest drug market, with an particularly passionate affair with cannabis. Mary Jane has come a long way since the “Just Say No” propaganda of the D.A.R.E. days. Now, millions of Americans legally light up in their home states, transforming from “criminals” to “consumers” faster than you can say “tax revenue.”
Here’s where things get sticky though. Despite the Biden administration’s vague promises of reform, cannabis remains stubbornly classified as a Schedule I substance at the federal level. This creates a peculiar predicament for freedom-loving Americans who appreciate both their Second Amendment rights and their evening toke.
You see, there’s this obscure interpretation of federal law that says if you consume cannabis – even legally in your state – you’re technically not allowed to own firearms. Let that sink in for a moment: in a country with more guns than people, where cannabis is legally sold in most states, you’re forced to choose between your constitutional right to bear arms and your state-sanctioned right to consume a plant.
As you might imagine, telling Americans they can’t have their guns AND their ganja isn’t exactly going over well. It’s a uniquely American saga that pits state rights against federal law, personal freedom against bureaucratic overreach, and common sense against, well… whatever you’d call this situation.
Let’s dive into this bizarre legal battleground where constitutional rights and cannabis collide.
As America’s cannabis landscape evolves, we’re witnessing a fascinating legal tug-of-war between state sovereignty and federal authority. The latest battleground? The constitutional rights of cannabis consumers to bear arms.
In a groundbreaking decision, the U.S. Court of Appeals for the Fifth Circuit recently reaffirmed that banning occasional marijuana users from owning firearms is unconstitutional. The case, known as U.S. v. Daniels, centers around a man who was sentenced to four years in prison after police found trace amounts of cannabis and firearms during a routine traffic stop. Talk about wrong place, wrong time!
The federal government, particularly under the Biden administration, has been performing some impressive mental gymnastics to justify their position. Their argument? Cannabis users with guns “endanger public safety,” “pose a greater risk of suicide,” and are more likely to commit crimes “to fund their drug habit.” They’ve even argued that cannabis consumers are “unlikely to store their weapons properly.” I guess they never met my ex-military uncle who meticulously organizes his gun safe while enjoying his evening edible.
But here’s where it gets really interesting. The Department of Justice claims the restriction is perfectly constitutional because it aligns with the nation’s history of disarming “dangerous” individuals. They’re essentially putting cannabis users in the same category as folks with domestic violence restraining orders. As someone who’s spent considerable time around both cannabis users and domestic abusers (professionally, of course), I can tell you there’s a slight difference in temperament.
The courts, however, aren’t buying it. As the Fifth Circuit pointed out, the government failed to prove that Daniels was “presently or even regularly intoxicated at the time of arrest.” They noted that even if the government had proven frequent intoxication, they offered “no Founding-era law or practice of disarming ordinary citizens ‘even if their intoxication was routine.'”
The ruling doesn’t completely invalidate the federal statute (known as § 922(g)(3)), but it does expose its shaky constitutional foundation. As the court stated, “This is not a windfall for defendants charged under § 922(g)(3),” but rather a recognition that the government’s enforcement approach is fundamentally flawed.
Meanwhile, the National Rifle Association (NRA) – not exactly known for their progressive stance on substances – acknowledges the absurdity of the situation. They point out that “marijuana use is no longer limited to the domain of indigenous religious customs or youth-oriented counterculture and now includes a wide variety of people who use it for medicinal or recreational reasons.” When even the NRA is suggesting your gun control measure might be a bit extreme, you know something’s amiss.
The result of all this legal wrangling? A patchwork of confusion where state-legal cannabis users must choose between their Second Amendment rights and their medicine or recreational preference. It’s a prime example of how federal prohibition creates more problems than it solves, forcing otherwise law-abiding citizens to become unwitting criminals simply for exercising multiple legal rights simultaneously.
Welcome to America, folks, where you can have your guns or your ganja, but apparently not both – at least until the courts finish sorting out this constitutional cannabis conundrum.
Let me be blunt – we’re caught in a classic American political pretzel. The Biden administration dangles the carrot of rescheduling cannabis to Schedule III, making vague promises that sound good on the campaign trail but do little to address the fundamental issues plaguing cannabis consumers, including their right to bear arms.
While some celebrate these baby steps toward reform, I’ve been around this block enough times to know that rescheduling is like putting a Band-Aid on a bullet wound. It might stop some bleeding, but it doesn’t address the underlying trauma. The gun rights issue is just one of many complications that arise from cannabis’s continued inclusion in the Controlled Substances Act (CSA).
Here’s the uncomfortable truth: there’s only one real solution, and it runs straight through the halls of Congress. The same body that created this mess with the CSA in 1971 is the only one with the power to truly fix it. Congress needs to completely remove cannabis from the CSA – not reschedule it, not modify its status, but fully deschedule it.
Think about it. Rescheduling to Schedule III would still leave cannabis in a weird legal limbo. Sure, it might make research easier and give Big Pharma more room to play, but what about the millions of Americans who use cannabis medicinally or recreationally in their state-legal markets? They’d still be federal criminals, still banned from purchasing firearms, still caught in the crossfire between state and federal law.
The only path forward is complete removal from the CSA, coupled with a federal framework that respects state markets while establishing basic national standards. This would resolve the gun rights issue overnight – no more choosing between your Second Amendment rights and your medicine or recreational preference.
Would I love to see Congress completely overhaul the CSA? Absolutely. The entire scheduling system is based on outdated science and political theater rather than actual harm reduction principles. But let’s be realistic – that’s about as likely as finding bipartisan agreement on… well, anything these days.
Instead, we need to focus on what’s achievable: complete cannabis descheduling. This isn’t just about guns and ganja – it’s about fixing a broken system that’s created countless legal paradoxes and unnecessary criminal penalties. It’s about acknowledging that the emperor has no clothes, that cannabis prohibition has failed, and that it’s time to move forward with a sensible federal policy.
Until Congress acts, we’ll continue to see these legal battles play out in courts across the country, watching judges try to reconcile constitutional rights with outdated federal drug laws. It’s a waste of judicial resources, taxpayer money, and most importantly, it’s a waste of Americans’ time and freedom.
The solution is clear. The only question is: how many more Americans need to get caught in this legal crossfire before Congress finally does its job?
Inspiration:
https://www.marijuanamoment.net/federal-court-reaffirms-that-ban-
on-gun-ownership-for-people-who-occasionally-use-marijuana-is-unconstitutional/
https://www.marijuanamoment.net/nra-says-federal-ban-on-
marijuana-amid-state-level-legalization-has-created-confusing-legal-landscape-for-gun-owners/
CANNABIS AND GUN RIGHTS, READ ON…
Cannabis News
MLK Day 2025: Cannabis and Civil Rights
Published
2 days agoon
January 20, 2025By
admin
It’s MLK Day once again.
I’ve been writing an MLK Day post on this blog for eight consecutive years. The theme of my posts is that cannabis is a civil rights issue, and that Dr. King would have advocated for ending prohibition based on that fact.
Each year, I have demonstrated with facts (upon facts upon facts) that the War on Drugs continues in insidious ways. In, 2023, which is the most recent year that FBI data is available, law enforcement officials made over 200,000 arrests for marijuana-related convictions. Those 200,000 arrests constitute roughly 25% of all drug-related arrests.
Sadly, arrests of black people constituted 29% of all drug arrests in 2023, although only 13.6% of Americans are black.
Heading into MLK Day weekend, President Biden announced that he is commuting the sentences of nearly 2,500 people convicted of non-violent drug offenses. The focus was predominantly on individuals “who received lengthy sentences based on discredited distinctions between crack and powder cocaine…”, as opposed to cannabis-related crimes. According to the Last Prisoner Project, “the total number of those incarcerated for cannabis who received commutations is not knows, but nine LPP constituents will be free.”
For all that Biden promised as to cannabis, it’s the least we could have asked. Under the new Trump administration, attention will quickly return to the frustrating marijuana rescheduling process. If cannabis ends up on Schedule III, criminal penalties for traffickers may soften, but make no mistake: possessing and distributing cannabis will still be a federal crime.
At the state level, where most arrest occur, progress has slowed in the last few years. Out here where I live in Oregon, with our 800 cannabis stores, it’s astonishing to think of 200,000 annual cannabis arrests– most for simple possession, no less.
There is a lot of work to do. Here are a short list of organizations if you’d like to get involved:
For prior posts in this series:
Cannabis News
No Smoking, No Vaping – What’s the Safest Way to Consume Cannabis Based on Your Genetics and Science?
Published
2 days agoon
January 20, 2025By
admin
The Safest Way To Consume Cannabis For Health, According To Science and Genetics
Marijuana legalization continues to help thousands of people.
Most especially those who need marijuana to treat conditions in a safer, more natural, and more cost-effective manner compared to pricey, addictive, and dangerous pharmaceutical medications. That said, not all weed is made the same: depending on where you get your weed, some of it may be grown using pesticides, which can be bad for your health especially when smoked. So yes, it does matter what kind of weed you’re smoking and where you got it from.
In addition, not all methods of consumption are also the same. Many consumers, particularly extremely health-conscious individuals, prefer not to smoke weed. Smoking weed that’s been grown with pesticides can also be dangerous for one’s health. It’s especially not recommended if you are immunocompromised,
That’s why a growing number of consumers prefer to explore the variety of other consumption methods available these days, such as edibles, tinctures, beverages, and cannabis oil to name a few.
Now, the results of a new study have just been published, suggesting that cannabis oil extracts may be the safest way to consume weed. Researchers studied MCT oils that contained high concentrations of CBD with some THC.
“Several studies have found damage to various chromosomal associated with cannabinoid use,” said the researchers. “Considering numerous studies demonstrating the genotoxicity of cannabis, it is noteworthy that many of these investigations have focused on individuals who consume cannabis through smoking or in cigarette form, normally rich in THC,” they said.
The researchers specifically found that extracts of cannabis sativa don’t exhibit genotoxic or mutagenic potential in doses that are commonly used by patients to manage anxiety, pain, epilepsy, and other conditions. “Although the current literature on cannabis sativa extract remains inconsistent, most evidence suggests that these extracts are safe for cells and DNA under both acute and chronic experimental conditions, even at high doses, in studies involving both male and female animals,” wrote the researchers.
Some consumers were alarmed recently when studies, albeit weak in nature, were published, which suggested that cannabis smoke had the potential to be genotoxic. That said, it still isn’t recommended for individuals who may be immunocompromised but there is no strong evidence that cannabis can indeed cause genetic mutations.
Since oral consumption of cannabis oil bypasses the respiratory system and allows patients a more accurate way to dose, it’s become the preferred method of consumption for many medical cannabis patients. Whether you’re young or old, the safety profile of cannabis oil has been proven; this is especially true if you wish to avoid respiratory harm.
The Role Of Quality Cannabis In Health
As cannabis consumers, there are many ways you can ensure that you’re medicating with clean, safe cannabis that’s free from dangerous contaminants. Pesticides aren’t the only contaminants to be aware of; street cannabis sold by dealers can be laced with toxic additives and even fatal ingredients, such as in the notorious case of the tainted THC vapes containing Vitamin E acetate. Other undesirable ingredients to take note of include residual solvents and heavy metals.
It’s also your role as a consumer to do research about the quality of cannabis you buy. Of course, it makes sense to only buy from licensed cannabis dispensaries since they can easily supply laboratory-tested cannabis products. From edibles to oils, flowers and more, licensed dispensaries can provide products that have a Certificate of Analysis or COA, which can either be printed on the packaging itself, accessed online, or via a QR code. A cannabis product with a COA can give you peace of mind that the product meets stringent testing and quality standards.
In addition, you can also seek out certified organic cannabis products. Of course, the fact that cannabis still isn’t federally legal means that there is nothing similar to a USDA Organic certification for weed, though some manufacturers make it easier for consumers these days to know if they are buying organic or not. For example, if you live in California, you can look for Clean Green Certified or OCal (weed that has been grown in standard that are comparable to organic).
Conclusion
If you are older or have pre-existing medical conditions, the best way to medicate with marijuana is by taking cannabis oil orally. It’s also extremely versatile, since it can be used to treat an array of conditions ranging from nausea to chronic pain, headaches, muscle pain, and so much more. While it may have reduced bioavailability compared to smoking, cannabis oil extracts do provide fairly quick relief for several conditions.
Smoking weed in any form, whether by flower, vape oil, or concentrates, should be avoided or limited altogether. There are also other potential consumption methods that are safer and more suitable for the immunocompromised, such as sprays, edibles, and topicals.
It also helps to carefully consider the type of cannabinoids you are consuming. For patients that need to medicate during the daytime, CBD or high-CBD products are always preferred. One must be careful with THC especially if you are older, operate machinery, or have no previous experience with psychoactive drugs. Always start with the lowest dose possible, and work your way to a higher dose slowly.
SAFEST WAY TO USE WEED, READ ON…
TikTok’s Double Standard on Marijuana And Alcohol
President Trump will decide marijuana rescheduling, federal reform
Are These the Top Cannabis Dispensaries In New York?
Panama And Cannabis
LA’s cannabis community steps up for wildfire relief
Does Your Dog Really Care When You Are Sad
Fun Life Lessons Learned From Spaghetti Westerns
America’s Constitutional Conundrum: Guns and Ganja
A Look At Martin Luther King And Cannabis
Meet the new and improved home of the growers, ILGM
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing1 year ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse